Filing Flows › Cardio Diagnostics Holdings (CDIO) › Q3 2025
Cardio Diagnostics Holdings (CDIO) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 12, 2025
Cardio Diagnostics Holdings (CDIO) reported revenue of $3K for the third quarter 2025 (Q3 2025), -57% from a year earlier and -62% from the quarter before.
Cardio Diagnostics Holdings, Q3 2025: revenue $3K (-57% year over year), net loss $1.7M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3K | -62% | -57% |
| Operating profit | −$1.7M | — | — |
| Net earnings | −$1.7M | — | — |
| Operating cash flow | −$1.4M | — | — |
What changed
Revenue was $3K in Q3 2025, down 57% year over year and down 62% from the previous quarter.
Operating costs exceeded revenue by $1.7M, an operating margin of -59950.9%. Total costs grew 21% against a revenue fall of 57%. The quarter ended with a net loss of $1.7M, wider than the previous quarter's $1.7M loss.
Operating cash flow was −$1.4M. Non-cash charges added back $40K of depreciation and amortization and $25K of share-based compensation. Working capital and other items added $256K. Capital expenditures of $163K exceeded it, leaving free cash flow of −$1.6M.
Questions
What was Cardio Diagnostics Holdings' revenue in the third quarter 2025?
Cardio Diagnostics Holdings (CDIO) reported revenue of $3K for the third quarter 2025 (Q3 2025), -57% from a year earlier and -62% from the quarter before.